ELOCTATE 1000

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktívna zložka:

COAGULATION FACTOR VIII

Dostupné z:

SANOFI - AVENTIS ISRAEL LTD

ATC kód:

B02BD05

Forma lieku:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Zloženie:

COAGULATION FACTOR VIII 1000 IU

Spôsob podávania:

I.V

Typ predpisu:

Required

Výrobca:

BIOGEN IDEC LIMITED , UK

Terapeutické oblasti:

COAGULATION FACTOR VII

Terapeutické indikácie:

ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.

Dátum Autorizácia:

2017-01-09